Login to Your Account



PHASE I

Viral/chemotherapy combo fights brain cancer

By Anette Breindl
Senior Science Editor

Thursday, June 2, 2016

A combination of retroviral gene therapy and chemotherapy administered as a prodrug significantly increased survival times of patients with recurrent high-grade glioma in a phase I trial.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription